<- Go Home

Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Market Cap

$1.5M

Volume

679.8K

Cash and Equivalents

$4.3M

EBITDA

-$30.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$37.9M

Profit Margin

64.36%

52 Week High

$14.50

52 Week Low

$0.75

Dividend

N/A

Price / Book Value

0.56

Price / Earnings

-0.02

Price / Tangible Book Value

4.99

Enterprise Value

$30.3M

Enterprise Value / EBITDA

-1.03

Operating Income

-$34.7M

Return on Equity

794.55%

Return on Assets

-32.43

Cash and Short Term Investments

$4.3M

Debt

$32.7M

Equity

$3.1M

Revenue

$58.9M

Unlevered FCF

-$8.9M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches